NCT00240812

Brief Summary

The purpose of the study is to determine if ibuprofen in combination with pseudoephedrine HCl in the treatment of nightime bedwetting in children is more effective than each drug alone and if the individual drugs are more effective than placebo.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
318

participants targeted

Target at P75+ for phase_2

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Completion

Last participant's last visit for all outcomes

November 1, 2002

Completed
3 years until next milestone

First Submitted

Initial submission to the registry

October 14, 2005

Completed
4 days until next milestone

First Posted

Study publicly available on registry

October 18, 2005

Completed
Last Updated

June 29, 2011

Status Verified

June 1, 2011

First QC Date

October 14, 2005

Last Update Submit

June 28, 2011

Conditions

Keywords

nocturnal enuresisbedwettingibuprofen

Outcome Measures

Primary Outcomes (1)

  • The mean reduction in wet nights from the 14-day baseline period to the 14-day treatment period.

Secondary Outcomes (1)

  • The proportion of subjects with at least a 50% reduction in wet nights from baseline; the mean number of wet nights during the 14 days of treatment.

Interventions

Eligibility Criteria

Age6 Years - 11 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • Subject has nighttime bedwetting
  • between the 5th and 95th percentiles for weight based on age and gender
  • has a minimum of eight wet nights per 14 days of the baseline period
  • healthy with no symptoms of any other complicating disease as determined by medical history review, physical examination, and clinical laboratory tests.

You may not qualify if:

  • Subject has daytime urinary incontinence or abnormal bowel habits (i.e. fecal incontinence or constipation)
  • has had episodes of dryness lasting one month or longer, at any time in the past
  • has a medical condition which may be relevant to participation in the study
  • has a known sensitivity or allergy to the study medications.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (1)

  • Caldwell PH, Codarini M, Stewart F, Hahn D, Sureshkumar P. Alarm interventions for nocturnal enuresis in children. Cochrane Database Syst Rev. 2020 May 4;5(5):CD002911. doi: 10.1002/14651858.CD002911.pub3.

Related Links

MeSH Terms

Conditions

EnuresisNocturnal Enuresis

Interventions

IbuprofenPseudoephedrine

Condition Hierarchy (Ancestors)

Urination DisordersUrologic DiseasesFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesMale Urogenital DiseasesBehavioral SymptomsBehaviorElimination DisordersMental Disorders

Intervention Hierarchy (Ancestors)

PhenylpropionatesAcids, CarbocyclicCarboxylic AcidsOrganic ChemicalsPropanolaminesAmino AlcoholsAlcoholsPropanolsAminesPhenethylaminesEthylamines

Study Officials

  • McNeil Consumer & Specialty Pharmaceuticals, a Division of Mc Neil-PPC, Inc. Clinical Trial

    McNeil Consumer & Specialty Pharmaceuticals, a Division of McNeil-PPC, Inc.

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
phase 2
Allocation
RANDOMIZED
Masking
DOUBLE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
INDUSTRY

Study Record Dates

First Submitted

October 14, 2005

First Posted

October 18, 2005

Study Completion

November 1, 2002

Last Updated

June 29, 2011

Record last verified: 2011-06